570 related articles for article (PubMed ID: 21788321)
21. Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception.
Patil CS; Jain NK; Singh VP; Kulkarni SK
Indian J Exp Biol; 2004 Apr; 42(4):361-7. PubMed ID: 15088685
[TBL] [Abstract][Full Text] [Related]
22. The neuronal NO synthase participation in the peripheral antinociception mechanism induced by several analgesic drugs.
Romero TR; Resende LC; Duarte ID
Nitric Oxide; 2011 Nov; 25(4):431-5. PubMed ID: 21875681
[TBL] [Abstract][Full Text] [Related]
23. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test.
Jesse CR; Bortolatto CF; Savegnago L; Rocha JB; Nogueira CW
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1838-43. PubMed ID: 18773934
[TBL] [Abstract][Full Text] [Related]
24. The synthetic peptide PnPP-19 induces peripheral antinociception via activation of NO/cGMP/K
Freitas AC; Silva GC; Pacheco DF; Pimenta AM; Lemos VS; Duarte ID; de Lima ME
Nitric Oxide; 2017 Apr; 64():31-38. PubMed ID: 28087360
[TBL] [Abstract][Full Text] [Related]
25. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint.
Pena-dos-Santos DR; Severino FP; Pereira SA; Rodrigues DB; Cunha FQ; Vieira SM; Napimoga MH; Clemente-Napimoga JT
Neuroscience; 2009 Nov; 163(4):1211-9. PubMed ID: 19647045
[TBL] [Abstract][Full Text] [Related]
26. Noradrenaline activates the NO/cGMP/ATP-sensitive K(+) channels pathway to induce peripheral antinociception in rats.
Romero TR; Guzzo LS; Perez AC; Klein A; Duarte ID
Nitric Oxide; 2012 Mar; 26(3):157-61. PubMed ID: 22330728
[TBL] [Abstract][Full Text] [Related]
27. Peripheral neuronal nitric oxide synthase activity mediates the antinociceptive effect of Crotalus durissus terrificus snake venom, a delta- and kappa-opioid receptor agonist.
Picolo G; Cury Y
Life Sci; 2004 Jun; 75(5):559-73. PubMed ID: 15158366
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats.
Iwamoto ET; Marion L
J Pharmacol Exp Ther; 1994 May; 269(2):699-708. PubMed ID: 7514222
[TBL] [Abstract][Full Text] [Related]
29. The role of nitric oxide in the local antiallodynic and antihyperalgesic effects and expression of delta-opioid and cannabinoid-2 receptors during neuropathic pain in mice.
Hervera A; Negrete R; Leánez S; Martín-Campos J; Pol O
J Pharmacol Exp Ther; 2010 Sep; 334(3):887-96. PubMed ID: 20498253
[TBL] [Abstract][Full Text] [Related]
30. Participation of the nitric oxide-cyclic GMP-ATP-sensitive K(+) channel pathway in the antinociceptive action of ketorolac.
Lázaro-Ibáñez GG; Torres-López JE; Granados-Soto V
Eur J Pharmacol; 2001 Aug; 426(1-2):39-44. PubMed ID: 11525769
[TBL] [Abstract][Full Text] [Related]
31. Peripheral estradiol induces temporomandibular joint antinociception in rats by activating the nitric oxide/cyclic guanosine monophosphate signaling pathway.
Fávaro-Moreira NC; Torres-Chávez KE; Fischer L; Tambeli CH
Neuroscience; 2009 Dec; 164(2):724-32. PubMed ID: 19679171
[TBL] [Abstract][Full Text] [Related]
32. Peripheral involvement of the nitric oxide-cGMP pathway in the indomethacin-induced antinociception in rat.
Ventura-Martínez R; Déciga-Campos M; Díaz-Reval MI; González-Trujano ME; López-Muñoz FJ
Eur J Pharmacol; 2004 Oct; 503(1-3):43-8. PubMed ID: 15496294
[TBL] [Abstract][Full Text] [Related]
33. Involvement of the nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway in the antihyperalgesic effects of bovine lactoferrin in a model of neuropathic pain.
Wang J; Zhang LC; Lv YW; Ji Y; Yan XJ; Xue JP
Brain Res; 2008 May; 1209():1-7. PubMed ID: 18406400
[TBL] [Abstract][Full Text] [Related]
34. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
[TBL] [Abstract][Full Text] [Related]
35. NO/cGMP production is important for the endogenous peripheral control of hyperalgesia during inflammation.
Alves DP; da Motta PG; Romero TR; Klein A; Duarte ID
Nitric Oxide; 2013 Jan; 28():8-13. PubMed ID: 22995857
[TBL] [Abstract][Full Text] [Related]
36. Involvement of L-arginine/NO/cGMP/K(ATP) channel pathway in the peripheral antinociceptive actions of ellagic acid in the rat formalin test.
Ghorbanzadeh B; Mansouri MT; Hemmati AA; Naghizadeh B; Mard SA; Rezaie A
Pharmacol Biochem Behav; 2014 Nov; 126():116-21. PubMed ID: 25278343
[TBL] [Abstract][Full Text] [Related]
37. TRPA1, NMDA receptors and nitric oxide mediate mechanical hyperalgesia induced by local injection of magnesium sulfate into the rat hind paw.
Srebro DP; Vučković SM; Savić Vujović KR; Prostran MŠ
Physiol Behav; 2015 Feb; 139():267-73. PubMed ID: 25449407
[TBL] [Abstract][Full Text] [Related]
38. Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats.
Araiza-Saldaña CI; Reyes-García G; Bermúdez-Ocaña DY; Pérez-Severiano F; Granados-Soto V
Eur J Pharmacol; 2005 Dec; 527(1-3):60-70. PubMed ID: 16305795
[TBL] [Abstract][Full Text] [Related]
39. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta.
Vetrovsky P; Boucher JL; Schott C; Beranova P; Chalupsky K; Callizot N; Muller B; Entlicher G; Mansuy D; Stoclet JC
J Pharmacol Exp Ther; 2002 Nov; 303(2):823-30. PubMed ID: 12388669
[TBL] [Abstract][Full Text] [Related]
40. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
Romero TR; Resende LC; Guzzo LS; Duarte ID
Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
